Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol gel plus pulsed dye laser vs pulsed dye laser alone for pediatric port wine stains
2010-022440-20Phase 3
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of timolol in port-wine stain (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Therapeutic success by Investigator Global Assessment at 1 month post-treatment.
02
Drugs
timolol
03
Conditions
port-wine stain
Beyond the preview
Go deeper on 2010-022440-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022440-20.